Clinical Trial Update: SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335) [Phase 3]

View source ↗

Summary

Phase 3 SAALT trial evaluated adding losartan to a reduced-sodium strategy for hypertension; results were posted after completion in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Cozaar (losartan)

Snippet

Sponsor: Organon and Co | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2010-08-11